Related Experiment Video
Updated: Sep 28, 2025

In Vitro Model of Coronary Angiogenesis
Published on: March 10, 2020
The Role of Angiogenesis and Arteriogenesis in Myocardial Infarction and Coronary Revascularization
Cristiano Spadaccio1,2, Antonio Nenna3, David Rose4
1Cardiac Surgery, Massachusetts General Hospital & Harvard Medical School, Boston, USA. cristianospadaccio@gmail.com.
Insights
Surgical revascularization improves survival in coronary artery disease by promoting blood vessel growth (angiogenesis and arteriogenesis). This review explores how these mechanisms enhance blood flow and preserve heart tissue, offering therapeutic potential.
Area of Science:
- Cardiovascular Biology
- Interventional Cardiology
- Translational Medicine
Background:
- Surgical myocardial revascularization offers long-term survival benefits for patients with multivessel coronary artery disease.
- The precise biological mechanisms driving these clinical benefits remain incompletely understood.
- Coronary collateralization, through angiogenesis and arteriogenesis, is a key endogenous mechanism for preserving myocardial viability during ischemia and predicts survival in coronary artery disease.
Purpose of the Study:
- To review existing clinical and basic science evidence on arteriogenesis and angiogenesis in coronary artery disease (CAD).
- To analyze the role of these vascularization processes in the context of coronary revascularization procedures.
- To elucidate the clinical significance and potential therapeutic applications of angiogenesis and arteriogenesis in CAD management.
Main Methods:
- Comprehensive literature review of experimental and clinical studies.
- Analysis of data on angiogenesis and arteriogenesis in both chronic CAD and post-revascularization settings.
- Synthesis of evidence linking vascularization mechanisms to clinical outcomes and therapeutic strategies.
Main Results:
- Evidence suggests myocardial revascularization can induce an angiogenetic response.
- Revascularization procedures themselves may act as triggers for endogenous angiogenesis.
- Coronary collateralization is a recognized predictor of long-term survival in CAD patients.
Conclusions:
- Angiogenesis and arteriogenesis are crucial endogenous mechanisms in CAD, contributing to myocardial protection.
- Myocardial revascularization may stimulate these vascularization processes, enhancing clinical benefits.
- Further research into these mechanisms could unlock novel therapeutic strategies for CAD.
Abstract:
Surgical myocardial revascularization is associated with long-term survival benefit in patients with multivessel coronary artery disease. However, the exact biological mechanisms underlying the clinical benefits of myocardial revascularization have not been elucidated yet. Angiogenesis and arteriogenesis biologically leading to vascular collateralization are considered one of the endogenous mechanisms to preserve myocardial viability during ischemia, and the presence of coronary collateralization has been regarded as one of the predictors of long-term survival in patients with coronary artery disease (CAD). Some experimental studies and indirect clinical evidence on chronic CAD confirmed an angiogenetic response induced by myocardial revascularization and suggested that revascularization procedures could constitute an angiogenetic trigger per se. In this review, the clinical and basic science evidence regarding arteriogenesis and angiogenesis in both CAD and coronary revascularization is analyzed with the aim to better elucidate their significance in the clinical arena and potential therapeutic use.
Related Concept Videos
Mechanism of Angiogenesis
Regulation of Angiogenesis and Blood Supply
Coronary Artery Disease V: Interprofessional Care
Angina IV: Management
Myocarditis I: Introduction

